Skip to content

Guardant Health GH Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$0-100%
NeoGenomics logo
NeoGenomicsNEO
$0
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$0-100%
Lucid Diagnostics logo
Lucid DiagnosticsLUCD
$0-100%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$30M

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$19.04B+255%
Enterprise value$19.65B+229%
P/S17.6×+11.2×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromConvertibleDebt.

The official record: Guardant Health’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardant Health's debt issuance proceeds?
Guardant Health (GH) reported debt issuance proceeds of $100.63M in Q4 2025.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.